However, the efficacy and potentiality of angiogenesis inhibition for tumor treatment is highlighted when a search in the U.S. National library of medicine (http://clinicaltrials.gov, accessed on 18 January 2019) for interventional clinical trials that are recruiting or not yet recruiting, using VEGF and cancer as keywords, retrieved 205 studies. The gene discussed is VEGFA; the disease is neoplasm.